Advertisement

Click here for more guidelines.

 
 




CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1996; 28:396-399
© 1996 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bertolet, B.
Right arrow Articles by Belardinelli, L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bertolet, B.
Right arrow Articles by Belardinelli, L

Bradycardia after heart transplantation: reversal with theophylline

BD Bertolet, DA Eagle, JB Conti, RM Mills, and L Belardinelli

Department of Medicine, University of Florida Health Sciences Center, Gainesville, Florida.

OBJECTIVES: We attempted to demonstrate that theophylline, an adenosine receptor antagonist, can reverse bradyarrhythmias after orthotopic heart transplantation. BACKGROUND: Sinus node dysfunction, primarily sinus bradycardia, frequently occurs after orthotopic heart transplantation and may lead to permanent pacemaker implantation. Endogenous adenosine has been implicated as a cause of such posttransplantation bradyarrhythmia. METHODS: Twenty-nine transplant recipients (group 1) were given theophylline after bradyarrhythmias developed after transplantation. Data in these patients were compared with those in a control group of 18 patients without bradyarrhythmias (group 2) who were not given theophylline. RESULTS: The mean heart rate in group 1 increased from 62 +/- 7 to 89 +/- 10 beats/min after administration of theophylline (p < 0.0001); the mean heart rate in group 2 was 88 +/- 12 beats/min. Patients in group 1 required more days of temporary atrial pacing (3.5 +/- 1 vs. 1.5 +/- 3, p < 0.04) before the administration of theophylline than did patients in group 2. The length of hospital stay after transplantation did not differ significantly between groups 1 and 2 (17 +/- 7.5 vs. 20 +/- 16 days, p = NS). Age, gender, underlying disease, preoperative use of amiodarone, graft ischemia time or the incidence of moderate to severe rejection were not different between patient groups. CONCLUSIONS: The use of theophylline for posttransplantation bradyarrhythmias increased heart rate and facilitated the withdrawal of chronotropic support. We conclude that theophylline offers effective and specific therapy for heart transplant patients with early bradyarrhythmias, reducing the need for implantation of a permanent pacemaker.


This article has been cited by other articles:


Home page
CirculationHome page
L. J. Morrison, C. D. Deakin, P. T. Morley, C. W. Callaway, R. E. Kerber, S. L. Kronick, E. J. Lavonas, M. S. Link, R. W. Neumar, C. W. Otto, et al.
Part 8: Advanced Life Support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations
Circulation, October 19, 2010; 122(16_suppl_2): S345 - S421.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, N. A. M. Estes III, R. A. Freedman, L. S. Gettes, A. M. Gillinov, G. Gregoratos, S. C. Hammill, D. L. Hayes, et al.
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons
J. Am. Coll. Cardiol., May 27, 2008; 51(21): e1 - e62.
[Full Text] [PDF]


Home page
CirculationHome page
Writing Committee Members, A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, N.A. M. Estes III, R. A. Freedman, L. S. Gettes, A. M. Gillinov, G. Gregoratos, S. C. Hammill, et al.
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons
Circulation, May 27, 2008; 117(21): e350 - e408.
[Full Text] [PDF]


Home page
Card Surg AdultHome page
L. U. Nwakanma, A. S. Shah, J. V. Conte, and W. A. Baumgartner
Heart Transplantation
Card. Surg. Adult, January 1, 2008; 3(2008): 1539 - 1578.
[Full Text]


Home page
CirculationHome page
Part 4: Advanced Life Support
Circulation, November 29, 2005; 112(22_suppl): III-25 - III-54.
[Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
J. C Coons, M. Shullo, K. Schonder, and R. Kormos
Terbutaline for Chronotropic Support in Heart Transplantation
Ann. Pharmacother., April 1, 2004; 38(4): 586 - 589.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
B. T. Bethea, D. D. Yuh, J. V. Conte, and W. A. Baumgartner
Heart Transplantation
Card. Surg. Adult, January 1, 2003; 2(2003): 1427 - 1460.
[Full Text]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement